SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-07
👔
Silence Therapeutics plc
@SLN_InsiderForm 4 Filing: Griffiths Richard Ian Sells shares of $SLN
INSIDER SALE
⚡ MATERIALITY: 3/10
corporate issuer
Silence Therapeutics plc
Ticker: $SLN
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-29
Shares: 1,544,374
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Griffiths Richard Ian, holds the title of 10% Owner at Silence Therapeutics plc.
On 2026-06-29, the insider transacted 1,544,374 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Griffiths Richard Ian (10% Owner) sold $0 of $SLN
Post-Transaction Position: 11,495,788 shares
SEC Accession No: 0001104659-26-080997 (CIK: 1846370)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.